New combo therapy could boost Alzheimer’s treatment: new Canadian researchStudy finds pairing existing drugs with nutrient-based compounds may improve effectiveness and reduce side effects. Why do some patients benefit more from PARP inhibitors than others? PARP inhibitors in recent years have significantly improved care for ovarian cancer. However, not all patients benefit and some develop resistance over time. Meet neffy: Health Canada approves epinephrine nasal spray for anaphylaxis The first needle-free epinephrine treatment for severe allergic reactions could be on the market in Canada as soon as this summer. Forged prescriptions are spiking in Alberta—especially in this one city The ACP is reminding pharmacies to report suspected or confirmed fraud. Manitoba college opens consultation on pharmacist-prescribed birth control Proposed changes would allow pharmacists to prescribe contraceptive pills, patches and vaginal rings. Is continuation of levothyroxine treatment in older adults always necessary? Study determines the proportion of adults aged 60 years or older who can successfully discontinue levothyroxine treatment. These patients without drug coverage are eagerly awaiting generic Ozempic in Canada Lower-cost alternatives could soon expand access for Canadians priced out of a popular drug. Mirtazapine shows some benefit in the treatment of methamphetamine use disorder Study examines the efficacy and safety of daily mirtazapine to treat moderate to severe methamphetamine use disorder in outpatients. AGEP: the rare but severe drug reaction pharmacists should know how to recognize Acute generalized exanthematous pustulosis (AGEP) presents with sterile pustules and systemic symptoms, and usually improves within days of stopping the trigger. Treating psoriasis: Take the elevator, not the stairs Instead of offering biologic therapies only when all other treatments have failed, why not start them as soon as psoriasis symptoms appear? First Previous 2 3 4 5 6 Next Last
